Key points are not available for this paper at this time.
Abstract Fifty-five of 62 women who inject drugs (WWID) selected long-acting cabotegravir (CAB-LA) over oral PrEP, and 51/55 received a first injection. More recent injection drug use and number of sexual partners were associated with selecting CAB-LA (P .05). Findings provide preliminary evidence of a strong preference for longer-acting products among WWID.
Roth et al. (Mon,) studied this question.